Allogene Therapeutics, Inc. · NASDAQ:ALLO

David D. Chang, M.D., Ph.D. reported a 5.00% stake in Allogene Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 9, 2025

David D. Chang, M.D., Ph.D. reported a 5.00% stake in Allogene Therapeutics, Inc., 11,043,100 shares, as a passive investor on Mar 31, 2025. Filed May 9, 2025 (Schedule 13G/A).

Stake
5.00%
Shares
11,043,100
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
David D. Chang, M.D., Ph.D.5.00%11,043,100
Chang 2006 Family Trust0.50%1,201,108
JEC 2019 Trust0.40%856,044
RTC 2019 Trust0.40%856,044

Source

View original at SEC

Related